Dore GJ - Search Results

1

Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.

Grebely J, Dore GJ, Altice FL, Conway B, Litwin AH, Norton BL, Dalgard O, Gane EJ, Shibolet O, Nahass R, Luetkemeyer AF, Peng CY, Iser D, Gendrano IN, Kelly MM, Hwang P, Asante-Appiah E, Haber BA, Barr E, Robertson MN, Platt H. Grebely J, et al. Among authors: dore gj. Ann Intern Med. 2022 Sep;175(9):1221-1229. doi: 10.7326/M21-4119. Epub 2022 Aug 9. Ann Intern Med. 2022. PMID: 35939812 Clinical Trial.

2

Public health challenges in hepatitis C virus infection.

Kaldor JM, Dore GJ, Correll PK. Kaldor JM, et al. Among authors: dore gj. J Gastroenterol Hepatol. 2000 May;15 Suppl:E83-90. doi: 10.1046/j.1440-1746.2000.02134.x. J Gastroenterol Hepatol. 2000. PMID: 10921388

3

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ. Law WP, et al. Among authors: dore gj. AIDS. 2004 May 21;18(8):1169-77. doi: 10.1097/00002030-200405210-00010. AIDS. 2004. PMID: 15166532 Clinical Trial.

4

Estimates of chronic hepatitis B virus infection in Australia, 2000.

O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. O'Sullivan BG, et al. Among authors: dore gj. Aust N Z J Public Health. 2004 Jun;28(3):212-6. doi: 10.1111/j.1467-842x.2004.tb00697.x. Aust N Z J Public Health. 2004. PMID: 15707165 Free article.

5

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.

Hallinan R, Byrne A, Amin J, Dore GJ. Hallinan R, et al. Among authors: dore gj. Aust N Z J Public Health. 2004 Dec;28(6):576-8. doi: 10.1111/j.1467-842x.2004.tb00050.x. Aust N Z J Public Health. 2004. PMID: 15707209 Free article.

6

Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.

Dore GJ, Thomas DL. Dore GJ, et al. Semin Liver Dis. 2005 Feb;25(1):18-32. doi: 10.1055/s-2005-864779. Semin Liver Dis. 2005. PMID: 15731995 Review.

7

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A, Treloar C, Dore GJ. Doab A, et al. Among authors: dore gj. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20. doi: 10.1086/427446. Clin Infect Dis. 2005. PMID: 15768340

8

Treatment for hepatitis C virus infection among current injection drug users in Australia.

Matthews G, Kronborg IJ, Dore GJ. Matthews G, et al. Among authors: dore gj. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S325-9. doi: 10.1086/427448. Clin Infect Dis. 2005. PMID: 15768342 Review.

9

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.

Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ. Amin J, et al. Among authors: dore gj. Epidemiol Infect. 2007 Jan;135(1):144-50. doi: 10.1017/S0950268806006388. Epub 2006 May 17. Epidemiol Infect. 2007. PMID: 16707030 Free PMC article.

10

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I, Kaldor JM, White PA, Dore GJ. Micallef JM, et al. Among authors: dore gj. J Viral Hepat. 2007 Jun;14(6):413-8. doi: 10.1111/j.1365-2893.2006.00812.x. J Viral Hepat. 2007. PMID: 17501762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page